Some large-cap stocks including momentum names like Pandora are trading in bear market territory after falling off their 52-week highs.» Read More
Some of Tuesday's midday movers:
Some of Friday's midday movers.
Nu Skin soared on earnings data, and RadioShack hired 2 former JC Penney executives. CNBC's Herb Greenberg questions whether this will pay off for RadioShack.
Some of the names on the move ahead of the open.
It’s time for the Lightning Round. Cramer makes the call on viewer favorites.
Take a look at some of Thursday's midday movers:
The trouble, according to Joe Mariano, president of the Direct Selling Association, that "there are a lot of pyramid schemes that like to disguise themselves as legitimate direct-selling companies."
Multi-level marketers get a pass from regulators, critics say. Are consumers on the losing end?
The story of the guy who started it all.
The multi-level marketing sales pitch may not be for everyone. Former distributors speak up.
Multi-level marketing is a big business, but one critic says it's also a big lie.
Oct 31- Nu Skin Enterprises Inc raised its full-year forecast for the sixth time this year, encouraged by strong demand for its new anti-ageing and body spa products under the ageLOC brand. Nu Skin shares rose 11 percent to $46.70 on the New York Stock Exchange on Wednesday morning.
Oct 31- Nu Skin Enterprises Inc's quarterly results handily beat Wall Street expectations on strong performance of its anti-ageing and nutritional supplement businesses in China, prompting the company to raise its full-year forecast for the sixth time.
--Abiomed Inc rescheduled second-quarter conference call to Nov. 1 at 8 am Eastern Time. --Accelrys Inc rescheduled third-quarter results to Oct. 31, after market. Its conference call will be held on Nov. 1, 9.30 am Eastern Time.
Oct 26- Individual donors to U.S. presidential candidates can contribute up to $2,500 for the state-by-state party nominating contests and another $2,500 for the general election.
Oct 2- Nautilus Minerals Inc:.
Take a look at some of Tuesday's midday movers:
Herbalife, whose stock tumbled last week after hedge fund manager David Einhorn asked a few questions on the company’s earnings call, is no stranger to controversy. Herb Greenberg sees some reasons to worry.
Jim Cramer and his researcher, Nicole Urken, discuss why Avon’s management situation needs a serious makeover.
When it comes to combating financial markets that all seem to move in unison, the options are getting so limited that some are questioning whether stock picking is a dying art.